| Code | Description | Claims | Beneficiaries | Total Paid |
|---|
| J2323 |
Injection, natalizumab, 1 mg |
424 |
379 |
$1.97M |
| 99214 |
Office or other outpatient visit for the evaluation and management of an established patient, moderate complexity |
3,247 |
2,569 |
$135K |
| 96413 |
Chemotherapy administration, intravenous infusion; up to 1 hour, single or initial substance |
1,082 |
959 |
$83K |
| 99213 |
Office or other outpatient visit for the evaluation and management of an established patient, low complexity |
2,212 |
1,657 |
$54K |
| 99215 |
Prolong outpt/office vis |
683 |
583 |
$54K |
| 95819 |
|
15 |
12 |
$3K |
| 96415 |
|
44 |
38 |
$2K |
| J2930 |
Injection, methylprednisolone sodium succinate, up to 125 mg |
49 |
41 |
$879.32 |
| 96367 |
|
43 |
37 |
$843.97 |
| 99358 |
Prolong nursin fac eval 15m |
24 |
13 |
$595.28 |
| G2211 |
Visit complexity inherent to evaluation and management associated with medical care services that serve as the continuing focal point for all needed health care services and/or with medical care services that are part of ongoing care related to a patient's single, serious condition or a complex condition. (add-on code, list separately in addition to office/outpatient evaluation and management visit, new or established) |
198 |
150 |
$341.91 |
| J7040 |
Infusion, normal saline solution, sterile (500 ml = 1 unit) |
26 |
24 |
$30.46 |